RxNorm Semantic Concepts Index - 132
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "132".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 13203 | Alpha amino isobutyric acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 13203 | Alpha amino isobutyric acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1320341 | Nifurtoinol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1320341 | Nifurtoinol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1320405 | Helianthemum canadense extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1320407 | anisum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1320409 | Spigelia marilandica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1320410 | Centaurea benedicta extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1320411 | Aquilegia vulgaris extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1320629 | Mycobacterium bovis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1320642 | picric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 13208 | Isophenoxazine synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 13208 | Isophenoxazine synthase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 13208 | Isophenoxazine synthase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1321 | bamethan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1321 | bamethan | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1321 | bamethan | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1321 | bamethan | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1321 | bamethan | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1321355 | Arthrospira platensis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1322046 | Rosa rugosa flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1322046 | Rosa rugosa flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 132208 | Ultrasound contrast media | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 132208 | Ultrasound contrast media | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1322428 | bovine thymus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1322428 | bovine thymus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1322526 | persimmon extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1322547 | Cynara scolymus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1322548 | Chamaelirium luteum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1322549 | Bacillus anthracis immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1322552 | Angostura bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1322554 | Mercurialis perennis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1322778 | Cryptosporidium parvum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1323279 | ferric chloride hexahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1324086 | Aspergillus ruber | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1324594 | Ulex europaeus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1324595 | California sheephead preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1324596 | European toad cutaneous gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1324596 | European toad cutaneous gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1324596 | European toad cutaneous gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1324597 | Juglans regia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1324604 | Gadoxetic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1324604 | Gadoxetic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1324604 | Gadoxetic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1324604 | Gadoxetic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1324834 | Alpha-2 HS-glycoprotein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1324834 | Alpha-2 HS-glycoprotein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1324834 | Alpha-2 HS-glycoprotein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1325 | Barbitone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1325 | Barbitone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1325 | Barbitone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1325 | Barbitone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1326 | Barbiturate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1326 | Barbiturate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1326 | Barbiturate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1326 | Barbiturate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1326077 | Bellis perennis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1326077 | Bellis perennis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1326501 | Carbo animalis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1326503 | Poa pratensis top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1328172 | interleukin-12, human recombinant | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1328285 | Ahnfeltiopsis concinna extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1328307 | Ranunculus bulbosus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1328307 | Ranunculus bulbosus whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1328308 | Fragaria vesca fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1328308 | Fragaria vesca fruit extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1328309 | Luffa operculata fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1328310 | Star of Bethlehem whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1328310 | Star of Bethlehem whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1328310 | Star of Bethlehem whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1328312 | poison hemlock flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1328312 | poison hemlock flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1328313 | Thymus serpyllum whole extract | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1328313 | Thymus serpyllum whole extract | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1328313 | Thymus serpyllum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1328313 | Thymus serpyllum whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1328315 | Porphyridium purpureum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1328529 | calcium sulfate, anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 132871 | Acetyl digitoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 132871 | Acetyl digitoxin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 132871 | Acetyl digitoxin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 132871 | Acetyl digitoxin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1328760 | Penicillium glabrum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 132879 | Ca-DTPA - Pentetate calcium trisodium | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 132879 | Ca-DTPA - Pentetate calcium trisodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 132879 | Ca-DTPA - Pentetate calcium trisodium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 132879 | Ca-DTPA - Pentetate calcium trisodium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 132881 | Metrodin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 132889 | Corbadrine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 132889 | Corbadrine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 132889 | Corbadrine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 132889 | Corbadrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 132889 | Corbadrine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 132889 | Corbadrine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 132889 | Corbadrine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 132892 | Leukotriene A | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 132892 | Leukotriene A | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 132907 | potassium phenethicillin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 132932 | Promoxolane | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 132932 | Promoxolane | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 132933 | Bovine growth hormone recombinant | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 132933 | Bovine growth hormone recombinant | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 132936 | Enzyme variant | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 132936 | Enzyme variant | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 132939 | Bovine somatotropin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 132939 | Bovine somatotropin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 132939 | Bovine somatotropin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1329877 | Salmonella enterica subsp. enterica serovar enteritidis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1329940 | Aspergillus flavus var. oryzae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 132995 | Sulfomyxin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 132995 | Sulfomyxin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 132995 | Sulfomyxin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 132996 | Carbomycin A | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 132996 | Carbomycin A | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1329960 | human placenta hydrolysate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 132997 | Carbomycin B | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 132997 | Carbomycin B | Full form of descriptor (FN) | NO |